These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 28726980)

  • 1. Association of Serum Osteoprotegerin With Vascular Calcification, and Cardiovascular and Graft Outcomes in Kidney Transplant Patients: Results From the KNOW-KT.
    Jeon HJ; Ryu JH; Kim MG; Huh KH; Lee KW; Kim CD; Kang KP; Ro H; Han S; Yang J;
    Transplantation; 2024 May; 108(5):1239-1248. PubMed ID: 38291579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.
    Sánchez-Santillán RN; Sierra-Vargas MP; González-Islas D; Aztatzi-Aguilar OG; Pérez-Padilla R; Orea-Tejeda A; Debray-García Y; Ortega-Romero M; Keirns-Davis C; Loaeza-Roman A; Rios-Pereda A
    BMC Pulm Med; 2024 Jul; 24(1):325. PubMed ID: 38965511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sclerostin and adverse outcomes in elderly patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    He W; Li C; Chen Q; Xiang T; Wang P; Pang J
    Aging Clin Exp Res; 2020 Oct; 32(10):2065-2072. PubMed ID: 31677125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study.
    Røysland R; Pervez MO; Pedersen MH; Brynildsen J; Høiseth AD; Hagve TA; Røsjø H; Omland T
    PLoS One; 2016; 11(7):e0160182. PubMed ID: 27463973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Validation of the Nomogram Based on von Willebrand Factor Predicting Mortality in Patients with Heatstroke.
    Wan L; Shi X; Yang J; Qian J; Wang F; Chen R; Tong H
    Ther Hypothermia Temp Manag; 2023 Dec; 13(4):191-199. PubMed ID: 37145896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
    Dominik N; Scheiner B; Zanetto A; Balcar L; Semmler G; Campello E; Schwarz M; Paternostro R; Simbrunner B; Hofer BS; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Simioni P; Reiberger T; Mandorfer M
    Aliment Pharmacol Ther; 2024 Jun; 59(11):1376-1386. PubMed ID: 38482706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study.
    Frankel DS; Meigs JB; Massaro JM; Wilson PW; O'Donnell CJ; D'Agostino RB; Tofler GH
    Circulation; 2008 Dec; 118(24):2533-9. PubMed ID: 19029465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Osteoprotegerin Levels Independently Predict All-cause Mortality in Patients with Chronic Kidney Disease: a Meta-analysis.
    Huang QX; Li JB; Huang XW; Jiang LP; Huang L; An HW; Yang WQ; Pang J; Li YL; Huang FX
    Int J Med Sci; 2019; 16(10):1328-1337. PubMed ID: 31692972
    [No Abstract]   [Full Text] [Related]  

  • 9. Von Willebrand Factor Antigen Levels Predict Poor Outcomes in Patients With Stroke and Cancer: Findings From the Multicenter, Prospective, Observational SCAN Study.
    Kawano T; Gon Y; Sakaguchi M; Yamagami H; Abe S; Hashimoto H; Ohara N; Takahashi D; Abe Y; Takahashi T; Okazaki S; Todo K; Mochizuki H; Sasaki T;
    J Am Heart Assoc; 2024 Feb; 13(3):e032284. PubMed ID: 38240254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the osteoprotegerin/RANKL/RANK axis and osteopontin in acute coronary syndrome.
    Vega-Rosales JA; Saucedo-Orozco H; Márquez-Velasco R; Cruz-Soto R; Zazueta-Salido DF; Koretzky SG; Salinas-Arteaga G; Guarner-Lans V; Pech-Manzano L; Pérez-Torres I; Tavera-Alonso C; Soto ME
    Arch Cardiol Mex; 2024 May; ():. PubMed ID: 38810225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESTIMATION OF VON WILLEBRAND FACTOR IN PATIENTS CARDIAC DISEASES.
    Ibrahim H; Hussein A
    Georgian Med News; 2023 Nov; (344):106-110. PubMed ID: 38236108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic effect of osteoprotegerin in patients with ischemic stroke: A systematic review and meta-analysis.
    Pang L; Lin H; Wei X; Wei W; Lan Y
    PLoS One; 2024; 19(5):e0303832. PubMed ID: 38820283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Eyileten C; Jarosz-Popek J; Jakubik D; Gasecka A; Wolska M; Ufnal M; Postula M; Toma A; Lang IM; Siller-Matula JM
    Front Cardiovasc Med; 2021; 8():728724. PubMed ID: 34778397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
    Gager GM; Jilma B; Winter MP; Hengstenberg C; Lang IM; Toma A; Prüller F; Wallner M; Kolesnik E; von Lewinski D; Siller-Matula JM
    Eur J Clin Invest; 2020 Nov; 50(11):e13304. PubMed ID: 32506444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing.
    Ostrowska M; Kubica J; Adamski P; Kubica A; Eyileten C; Postula M; Toma A; Hengstenberg C; Siller-Matula JM
    Front Cardiovasc Med; 2019; 6():176. PubMed ID: 31850373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Siller-Matula J; Lang IM; Schoergenhofer C; Roest M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1730-1738. PubMed ID: 28726980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
    Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
    Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial.
    Bjerre M; Hilden J; Kastrup J; Skoog M; Hansen JF; Kolmos HJ; Jensen GB; Kjøller E; Winkel P; Flyvbjerg A; Gluud C;
    Scand J Clin Lab Invest; 2014 Nov; 74(8):657-64. PubMed ID: 25026506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention.
    Reed GW; Masri A; Griffin BP; Kapadia SR; Ellis SG; Desai MY
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313281
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.